NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • About Patient and Public Involvement
      • Our Work with Patients and the Public
      • Learn More About Our Research
      • Patient Involvement Blog
      • External Links
    • For Patients, Carers and the Public
      • Current Listings for Involvement
      • REGISTER INTEREST
      • Patient and Public Involvement Workshops
    • PPI Resources for Researchers
      • PPI Strategy
      • A Researcher’s Guide to PPI
      • PPI Resources for Researchers
      • PPI Briefing Notes
      • PPI Case Studies
      • PPI Advisory Group
      • PPI Events for Researchers
      • Post a PPI Listing
      • Public Engagement for Researchers
      • Public Engagement Case Studies
  • Training Hub
    • Training Hub
    • Fellowships
    • Funding Opportunities
    • Clinical Researchers and Scientists
    • Nurses, Midwives and Allied Health Professionals
    • Next Generation Leaders Programme
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Vaccines for Emerging and Endemic Diseases

You are here: Home > News listings for Vaccines for Emerging and Endemic Diseases

News for Vaccines and Endemic Diseases

Oxford COVID-19 vaccinations begin

4 January 2021 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

The NHS has launched the roll-out of the new Oxford AstraZeneca coronavirus vaccine, with patients at Oxford University Hospitals NHS Foundation Trust (OUH) the very first to get the life-saving jab. Among the first to be vaccinated was Prof Andrew Pollard, the Oxford BRC investigator who has played a key role in developing the vaccine. … Read more

Key step for hepatitis research as patient database created

10 December 2020 · Listed under Clinical Informatics and Big Data, Vaccines for Emerging and Endemic Diseases

For the first time, a comprehensive database comprising an initial cohort of more than 1,300 patients with chronic hepatitis B or hepatitis C infections has been developed for potential future research into the conditions. The methodology to develop a pipeline to collect and manage this data has been presented in a paper published in BMJ … Read more

Peer-reviewed results of phase 3 Oxford coronavirus vaccine trial demonstrate efficacy

8 December 2020 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

The vaccine against SARS-CoV-2 developed by researchers from the University of Oxford and AstraZeneca is safe and effective according to the peer-reviewed findings of the phase 3 trial. The pooled analysis of the trial across two different dose regimens resulted in an average efficacy of 70.4%; however, one dosing regimen achieved 90% efficacy. The new study, … Read more

Oxford University breakthrough on global COVID-19 vaccine

23 November 2020 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

The University of Oxford, in collaboration with AstraZeneca plc, has announced interim trial data from its Phase III trials that shows its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 and offers a high level of protection. The interim analysis indicates that the vaccine is 70.4% effective when combining data from two dosing regimens. … Read more

Health economists outline possible criteria for allocating COVID-19 vaccine

3 September 2020 · Listed under Vaccines for Emerging and Endemic Diseases

NIHR Oxford BRC-supported health economics researchers have published a paper outlining the possible criteria that governments might use to prioritise who gets a COVID-19 vaccine once one has been approved for use. The article – ‘How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton’ … Read more

BRC researchers’ work recognised with Vice-Chancellor’s Awards

30 July 2020 · Listed under Molecular Diagnostics, Surgical Innovation and Evaluation, Vaccines for Emerging and Endemic Diseases

A number of Oxford BRC-supported researchers have been recognised in this year’s University of Oxford Vice-Chancellor Innovation Awards. The Vice-Chancellor Innovation Awards celebrate research-led innovation that is having societal or economic impact. Prof Robert MacLaren, who leads the BRC’s Surgical Innovation theme, was named winner of the Inspiring Leadership category for his work on creation and spin-out of … Read more

Oxford coronavirus vaccine produces strong immune response, study finds

20 July 2020 · Listed under Vaccines for Emerging and Endemic Diseases

A team of scientists at Oxford University’s Jenner Institute and Oxford Vaccine Group has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus. The results of the Phase I/II trial, published today in The Lancet, indicate no early safety concerns and show the vaccine induces a strong immune … Read more

Oxford COVID-19 vaccine to begin phase II/III human trials

22 May 2020 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers. The phase I trial in healthy adult volunteers began in April. More than 1,000 immunisations have been completed and follow-up is currently ongoing. The next study will enrol up to 10,260 adults and children … Read more

Oxford COVID-19 vaccine begins human trial stage

23 April 2020 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine. Of the first two volunteers to take part, one likewise received the vaccine and … Read more

BRC funds three further COVID-19 studies

21 April 2020 · Listed under COVID-19, Gastroenterology and Mucosal Immunity, Haematology and Stem Cells, Vaccines for Emerging and Endemic Diseases

Three more studies are being funded by the NIHR Oxford Biomedical Research Centre (BRC) to look at the way the body interacts with COVID19; these include assessing the safety of a new vaccine; the role that antibodies might play in plasma therapy; and blood biomarkers that determine adverse reactions in those that have been infected. … Read more

Oxford COVID-19 vaccine programme opens for clinical trial recruitment

27 March 2020 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

University of Oxford researchers, working in an unprecedented vaccine development effort to prevent COVID-19, have started screening healthy volunteers ahead of a vaccine trial. The NIHR Oxford Biomedical Research Centre (BRC) provided essential funding to get the trial up and running. The team will enrol healthy volunteers aged between 18 and 55, who, if they … Read more

Oxford researchers to play key role in fight-back against COVID-19

20 March 2020 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19, Gastroenterology and Mucosal Immunity, Partnerships for Health, Wealth and Innovation, Respiratory, Vaccines for Emerging and Endemic Diseases

Researchers supported by the NIHR Oxford Biomedical Research Centre will play a crucial role in tackling the current COVID-19 pandemic, ranging from the development of a new vaccine to developing the most effective drug treatments for people who have contracted the virus. A team from the Oxford Vaccine Group and the University of Oxford’s Jenner … Read more

Working together to find a cure to HIV

21 February 2020 · Listed under Vaccines for Emerging and Endemic Diseases

Results from a study testing a new ‘kick and kill’ method of reducing the size of the undetected HIV reservoir in people living with the virus were published in The Lancet this week. RIVER (Research in Viral Eradication of HIV Reservoirs) is the first ever randomised clinical trial to test this approach to curing HIV. … Read more

Successful Nepal study for typhoid vaccine developed in Oxford

13 December 2019 · Listed under Vaccines for Emerging and Endemic Diseases

A large field study in Nepal has shown that a typhoid conjugate vaccine (TCV) developed in Oxford is over 81 percent effective in tackling the disease. A single dose of the vaccine was found to be safe and effective in reducing typhoid in children aged 9 months to 16 years in an endemic setting. Attempts … Read more

NIHR Oxford BRC Senior Research Fellows named

14 May 2019 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, Multimorbidity and Long-Term Conditions, Musculoskeletal, Neurological Conditions, Other News, Respiratory, Vaccines for Emerging and Endemic Diseases

The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows. They were chosen from an extremely strong field of 47 applicants from across the scientific and clinical community because they demonstrated that their research was high impact and of high quality . They were also able to demonstrate leadership, independence … Read more

BRC researchers elected Fellows of Academy of Medical Sciences

8 May 2019 · Listed under Antimicrobial Resistance and Modernising Microbiology, Gastroenterology and Mucosal Immunity, Vaccines for Emerging and Endemic Diseases

Three Oxford BRC-supported researchers are among eight University of Oxford scientists elected to join the prestigious Fellowship of the Academy of Medical Sciences (AMS) this year. The BRC researchers among the new Fellows are: Professor Helen McShane, Professor of Vaccinology in the Nuffield Department of Medicine, Deputy Director of the Medical Sciences Division and Director … Read more

Oxford medical researchers win prestigious national awards

14 March 2019 · Listed under Antimicrobial Resistance and Modernising Microbiology, Multimorbidity and Long-Term Conditions, Musculoskeletal, Respiratory, Stroke and Vascular Dementia, Vaccines for Emerging and Endemic Diseases

Four leading healthcare academics in Oxford have received a prestigious national award. The University of Oxford professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”. The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre … Read more

HIV remission achieved in second patient

5 March 2019 · Listed under Vaccines for Emerging and Endemic Diseases

A second person has experienced sustained remission from HIV-1 after ceasing treatment, ten years after the first such case. The case was reported in a paper to be published in Nature. Like the first such case, known as the ‘Berlin Patient’, the second patient was treated with stem cell transplants from donors carrying a genetic … Read more

Oxford medical researchers win prestigious national awards

23 February 2018 · Listed under Antimicrobial Resistance and Modernising Microbiology, Diabetes and Metabolism, Gastroenterology and Mucosal Immunity, Haematology and Stem Cells, Obesity, Diet and Lifestyle, Partnerships for Health, Wealth and Innovation, Stroke and Vascular Dementia, Surgical Innovation and Evaluation, Vaccines for Emerging and Endemic Diseases

Leading health researchers in Oxford have been recognised in a prestigious national competition. Eight professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”. The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre … Read more

World-first NHS trial for universal flu vaccine

3 October 2017 · Listed under Vaccines for Emerging and Endemic Diseases

The world’s first widespread human testing of a flu vaccine which NIHR Oxford BRC researchers hope will protect more over 65-year-olds against influenza has begun in the NHS. More than 10,000 people aged 65 and over will be asked to take part in a study supported by the National Institute for Health Research (NIHR) and … Read more

  • 1
  • 2
  • 3
  • Next Page »

Vaccines for Emerging and Endemic Diseases Theme

  • Introduction
  • Patient & Public Involvement in the Vaccines Theme
  • Contacts
  • Videos for this Theme
  • News for this Theme
  • General News Listings

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced bimonthly and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2021 NIHR Oxford Biomedical Research Centre

Cookies

This site uses cookies See our data control and privacy page